Skip to content

Applied BioSciences Corp.

company.status.inactive

CIK 1607549fmd_1TWBGYWEVK5X42AK4QMP1BW9EKManufacturing · Grain Mill ProductsTemplate: Standard

Coverage: Apr 01, 2013 to Dec 31, 2019, 24 periods

Latest annual · FY2019

Millions
Total revenues
1
Gross profit
0
Operating income
(3)
Net income
(3)
Free cash flow
(1)

Latest quarter · Q3 FY2020

Millions
Total revenues
0
Gross profit
0
Operating income
(1)
Net income
(1)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2016 to FY2019
n/m

Applied BioSciences Corp. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2019FY2018ChangeSource
Revenue$707,062$197,554+257.9%10-K 2019-07-01 · proof
Gross profit$185,288$42,005+341.1%10-K 2019-07-01 · proof
Operating income-$2.6 million-$2.4 million10-K 2019-07-01 · proof
Net income-$2.7 million-$2.4 million10-K 2019-07-01 · proof
Cash from operating activities-$905,051-$673,46710-K 2019-07-01 · proof
Free cash flow-$906,606-$678,16610-K 2019-07-01 · proof
Total assets$3.7 million$705,327+417.7%10-K 2019-07-01 · proof
Total liabilities$374,266$35,885+943%10-Q 2020-02-18 · proof
Cash and cash equivalents$47,044$60,934-22.8%10-K 2019-07-01 · proof
What was Applied BioSciences Corp.'s revenue in fiscal 2019?
Applied BioSciences Corp. reported revenue of $707,062 for fiscal 2019 (the year ended Mar 31, 2019), against $197,554 the year before (+257.9%). Source: the 10-K filed with the SEC on Jul 1, 2019. SEC
What was Applied BioSciences Corp.'s gross profit in fiscal 2019?
Applied BioSciences Corp. reported gross profit of $185,288 for fiscal 2019 (the year ended Mar 31, 2019), against $42,005 the year before (+341.1%). Source: the 10-K filed with the SEC on Jul 1, 2019. SEC
What was Applied BioSciences Corp.'s operating income in fiscal 2019?
Applied BioSciences Corp. reported operating income of -$2.6 million for fiscal 2019 (the year ended Mar 31, 2019), against -$2.4 million the year before. Source: the 10-K filed with the SEC on Jul 1, 2019. SEC
What was Applied BioSciences Corp.'s net income in fiscal 2019?
Applied BioSciences Corp. reported net income of -$2.7 million for fiscal 2019 (the year ended Mar 31, 2019), against -$2.4 million the year before. Source: the 10-K filed with the SEC on Jul 1, 2019. SEC
What was Applied BioSciences Corp.'s cash from operating activities in fiscal 2019?
Applied BioSciences Corp. reported cash from operating activities of -$905,051 for fiscal 2019 (the year ended Mar 31, 2019), against -$673,467 the year before. Source: the 10-K filed with the SEC on Jul 1, 2019. SEC
What was Applied BioSciences Corp.'s free cash flow in fiscal 2019?
Applied BioSciences Corp. reported free cash flow of -$906,606 for fiscal 2019 (the year ended Mar 31, 2019), against -$678,166 the year before. Source: the 10-K filed with the SEC on Jul 1, 2019. SEC
What are Applied BioSciences Corp.'s total assets?
As of Mar 31, 2019, Applied BioSciences Corp. reported total assets of $3.7 million, against $705,327 a year earlier (+417.7%). Source: the 10-K filed with the SEC on Jul 1, 2019. SEC
What are Applied BioSciences Corp.'s total liabilities?
As of Mar 31, 2019, Applied BioSciences Corp. reported total liabilities of $374,266, against $35,885 a year earlier (+943%). Source: the 10-Q filed with the SEC on Feb 18, 2020. SEC
What are Applied BioSciences Corp.'s cash and cash equivalents?
As of Mar 31, 2019, Applied BioSciences Corp. reported cash and cash equivalents of $47,044, against $60,934 a year earlier (-22.8%). Source: the 10-K filed with the SEC on Jul 1, 2019. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1607549&period_type=annual&limit=5"

Information only, not investment advice.